Living & Wellbeing
Understanding Healthcare Disparities in Colorectal Cancer
In the United States, an estimated 147,950 people were diagnosed with cancer of the colon or rectum in 2020. It is one of the most highly diagnosed cancers in the US, with 12 percent of cases diagnosed in people under the age of 50.[i] Additionally, more than 20 percent of Americans with colorectal cancer have metastatic disease at diagnosis. Metastatic disease means the cancer has already begun to spread to other parts of the body.[ii] The COVID-19 pandemic has revealed flaws within healthcare...
Living & Wellbeing
Know the Mutational Status of Your Cancer: Biomarker Testing in Metastatic Melanoma and Metastatic Colorectal Cancer
If you’ve recently been diagnosed with metastatic melanoma or metastatic colorectal cancer, chances are you’ve had to familiarize yourself with a lot of new terms and complicated concepts. One term you may not have heard before is “biomarker.” As researchers learn more about how cancer cells develop, grow, and spread, more attention is being paid to the role biomarkers play in these processes. For patients, undergoing biomarker testing helps their doctor/healthcare team determine whether or not...
Living & Wellbeing
Fight Fear with Facts: Three Tips That May Help You Continue Your Lung Cancer Treatment During the COVID-19 Pandemic
Fight fear with facts and learn more about ways that may help you safely continue your treatment plans and attend regularly scheduled doctors’ visits. We’ve addressed some of the biggest stressors facing lung cancer patients during this unprecedented time.Working with Your Doctor to Continue TreatmentA lot is uncertain right now, but your treatment plan does not have to be. While it can be scary to leave the safety of your home, it is crucial that decisions regarding your treatment plan are made...
Living & Wellbeing
Using ‘Omics to Understand the Rise in Breast Cancers Among Young Asians
By Get Science Staff - This article originally published on Get Science Asian women, compared to their counterparts in western countries, are diagnosed with breast cancer at earlier ages and face a worse prognosis. In an effort to better understand this patient population, scientists from Pfizer and Samsung Medical Center (SMC) in Seoul, Korea, have embarked on a multi-phase project to do multi-omic profiling of the tumors of some 187 younger Korean breast cancer patients. Multi-omics refers...